Thomas Moore, MD
Infectious Disease · Wichita, KSNPI 1407851181
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $32,100 of the $37,198 with a category attached, or 86.3%. Aimmune Therapeutics, Inc. accounts for 96.7% of it on its own, with 24 other manufacturers making up the rest. Reporting peaked in 2024 at $34,400 and has fallen 93.9% since, to $2,102 in 2025. Among infectious disease clinicians in KS with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 82 payments — averaging $453.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Aimmune Therapeutics, Inc.$36K
- AbbVie$247
- Takeda Pharmaceuticals U.S.A., Inc.$114
- Melinta Therapeutics, LLC$96
- Pfizer$66
- Octapharma USA, Inc.$62
- plus $628 from 19 others
What the payments were for
- Consulting fees$400%
- Speaking & faculty fees$32,10086%
- Travel & lodging$3,5159%
- Food & beverage$1,5434%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Aimmune Therapeutics, Inc. | 21 | $35,984 |
| AbbVie(2 entities) | 11 | $247 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $114 |
| Melinta Therapeutics, LLC | 7 | $96 |
| Pfizer | 3 | $66 |
| Octapharma USA, Inc. | 3 | $62 |
| ADMA Biomanufacturing LLC | 3 | $60 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $59 |
| Insmed, Inc. | 3 | $55 |
| Merck | 3 | $51 |
| Paratek Pharmaceuticals, Inc. | 3 | $51 |
| Gilead | 2 | $42 |
| Hospira, Inc. | 2 | $35 |
| Grifols USA, LLC | 2 | $34 |
| Tetraphase Pharmaceuticals, Inc. | 2 | $33 |
| Viiv Healthcare Company | 2 | $33 |
| Ferring Pharmaceuticals Inc. | 1 | $28 |
| Davol Inc. | 1 | $26 |
| Nestle Healthcare Nutrition Inc. | 1 | $22 |
| Shionogi Inc | 1 | $19 |
| Amgen | 1 | $17 |
| CSL Behring | 1 | $17 |
| Convatec Inc. | 1 | $16 |
| Cormedix Inc. | 1 | $16 |
| Astellas Pharma US Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ZENPEP$35,784
How this compares
$37,198 in reported general payments places this provider in the 95th percentile of 56 infectious disease providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Daptomycin | 37 | $31,448 |
| ErtapenemErtapenem Sodium | 13 | $6,443 |
| CeftriaxoneCeftriaxone Sodium | 15 | $3,572 |
| Tenofovir Disoproxil Fumarate | 12 | $3,505 |
| Cefdinir | 38 | $2,726 |
| Cephalexin | 43 | $2,298 |
| Clindamycin Hcl | 36 | $2,065 |
| Doxycycline Hyclate | 24 | $1,971 |
| Linezolid | 14 | $1,538 |
| Methenamine Hippurate | 19 | $1,300 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 58 | $1,207 |
| Metronidazole | 41 | $731 |
| Penicillin V Potassium | 22 | $627 |
| Ciprofloxacin Hcl | 35 | $541 |
| Fluconazole | 20 | $490 |
Paid to pharmacies, not to this prescriber.
Other infectious disease in Wichita
- Maha AssiWichita$9K
- Margaret HaganWichita$4K
- Garret SeilerWichita$2K
- Keck HartmanWichita$2K
- Jerry PeterieWichita$2K
- Shelley JonesWichita$2K
- Wissam El AtrouniKansas City$15K
- John FriedOverland Park$7K
- Marjorie WongskhaluangLeawood$5K
- Apoorv KalraOverland Park$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.